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 1 
GENERAL INTRODUCTION 
 Synthesis of natural products or their analogs is interesting and challenging work. 
During the course of the investigation, chemists can not only prepare various kinds of 
bioactive compounds, but also discover new synthetic methodologies. The first chapter of 
this thesis deals with the development of modified methods to synthesize chrysosplenol B, 
chrysosplenol D, and their analogs. Both chrysosplenol B and chrysosplenol D have the 
flavone skeleton with 3-methoxyl and 5-hydroxyl groups. They have ability to potentiate the 
potent anti-malarial activity of artemisinin and have ability to potentiate the activity of 
norfloxacin. The second chapter deals with the synthetic effort towards  
3-(carboxymethylthio)-picolinic acid and a functionalized analog. They were synthesized in 
order to determine the minimum structural requirements for activity. This may enable 
researchers to study the mechanisms of molecular recognition of phosphoenolpyruvate (PEP) 
and oxaloacetate (OAA) by cytosolic phosphoenolpyruvate carboxykinase (cPEPCK). 
 
Explanation of Thesis Format 
 This thesis is divided into two chapters preceded by introductions. All the chapters 
are treated as separate sections. The numbering of the compounds, schemes and references 
are, therefore, listed independently in each section. The first chapter deals with the synthesis 
of chrysosplenol B, chrysosplenol D and their analogs. The second chapter deals with the 
synthesis of 3-(carboxymethylthio)-picolinic acid and its analog. A general summary of both 
papers follows the second chapter. 
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CHAPTER 1 
Synthesis of chrysosplenol B and chrysosplenol D and their analogs 
 
Introduction 
 Flavonoids are a class of phenolic compounds widely distributed in plants. Over one 
thousand individual types are known, and the list is constantly expanding. It has been found 
that components of this kind have many medical functions, such as diuretic, laxative, 
antispasmodic, antihypertensive and anti-inflammatory actions.
1 
 
 Artemisia annua L. (Asteraceae) is an annual herb endemic to the northern parts of 
Chahar and Suiyuan provinces in China where it is known as ‘quinghao’ and it has been used 
to treat chills and fever for more than 2000 years.
2, 3 
It had been reported that some flavones 
from A. annua potentiated the antimicrobial activity of artemisinin against Plasmodium 
falciparum and other malarial causing parasites.
4,5
 It has been proposed that this activity is 
due to its inhibition of the multidrug resistant (MDR) pumps in Plasmodium falciparum and 
in Staphylococcus aureus.
6
 Flavonols which bear a free hydroxyl group at C-3 were 
ineffective as inhibitors of the S. aureus MDR pump.
4
 Chrysosplenol B (1), also known as 
chrysosplenetin, and chrysosplenol D (2) are isolated from A. annua 
3-6
 and showed 
potentiated artemisinin activity against Plasmodium falciparum. Both flavonols bear 
methoxy groups at C-3 as shown in Figure 1.
3 
 
 3 
 
 
 
 
 
Chrysosplenol B (1) and chrysosplenol D (2) are also isolated from Chrysosplenium 
plants
7-9
, a medicinal herb for the treatment of the common cold, which is considered to be 
mainly due to rhinovirus infection. Tsuchiya and coworkers reported that 3-methoxyl and 5-
hydroxyl groups on the flavone skeleton conferred potent specific antiviral activity against 
rhinovirus.
7
 Both chrysosplenol B (1) and chrysosplenol D (2) bear 3-methoxyl and 5-
hydroxyl groups. 
  The 3-methoxylated flavones are rare in nature. Therefore, total synthesis of 
chrysosplenol B (1) and chrysosplenol D (2) has been studied.
6, 10, 11
 Fukui and coworkers 
started the synthesis of chrysosplenol B with conversion of iretol (3) to 2, 4, 6-trihydroxy- 
3, ω-dimethoxyacetophenone (4) by a Hoesch condensation with methoxyacetonitrile. The 
ketone was subjected to the Allan-Robinson flavone synthesis using o-benzylvanillic 
anhydride (5) to give 4’-benzyloxy-5, 7-dihydroxy-3, 3’, 6-trimethoxyflavone (6). The partial 
methylation of hydorxyflavone (6) with diazomethane gave 4’-benzyloxy-5-hydroxy-3, 3’, 6, 
7-tetramethoxyflavone (7), which was then debenzylated to give 4’, 5-dihydroxy-3, 3’, 6, 7-
tetramethoxyflavone, chrysosplenol B (1).
10 
 
Chrysosplenol D (2) Chrysosplenol B (1) 
Figure 1 
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About a year later, Fukui and Nakayama synthesized chrysosplenol D (2) in similar 
manner. By using the method of Allan-Robinson’s flavone synthesis, the reaction of the 
ketone 4 with 3, 4-dibenzyloxybenzoic anhydride (8) and potassium 3, 4-
dibenzyloxybenzoate, followed by treatment with alcoholic potassium hydroxide gave a 
mixture of flavones. The mixture was acetylated without further purification to yield 5, 7-
diacetoxy-3’, 4’-dibenzyloxy-3, 6-dimethoxyflavone (9). Treatment of flavone 9 with dilute 
alkali gave 3’, 4’-dibenzyloxy-5, 7-dihydroxy-3, 6-dimethoxyflavone (10). The partial 
methylation of flavone 10 gave 3’, 4’-dibenzyloxy-5-hydroxy-3, 6, 7-trimethoxyflavone (11). 
The debenzylation of flavone 11 yielded chrysosplenol D (2). This synthesis gave 
chrysosplenol D (2); however, it only gave 26% yield of flavone 9 from ketone 4.
11 
Scheme 1. Synthesis of chrysosplenol B (1) 
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Chrysosplenol D (2) was also synthesized by Kraus and Roy using a different route as 
shown in Scheme 3. Chalcone 14 was synthesized via an aldol condensation of ketone 12 
with aldehyde 13. Dihydroflavonol 15 was formed from Algar-Flynn-Olyamada (AFO) 
reaction of chalcone 14. Iodine oxidation of 15 produced flavonol 16 in 78% yield. 
Compound 16 was methylated to afford 3-methoxyflavone 17. Aluminum tribromide 
mediated selective demethylation of 3-methoxyflavone 17 and debenzylation of 18 using a 
catalytic amount of 10% Pd/C afforded chrysosplenol D (2).
6
 
Scheme 2. Synthesis of chrysosplenol D (2) by Fukui and Nakayama 
+ 
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When we tried to reproduce this procedure, the AFO reaction did not proceed very 
well. This reaction gave mostly starting material.  
  Therefore, we report herein an alternate synthesis of chrysosplenol D (2). The 
synthesis of chrysosplenol B (1) was carried out by a modification of this route. 
 
H2 
Pd/C 18 
Chrysosplenol D (2) 
Scheme 3. Synthesis of chrysosplenol D (2) by Kraus and Roy 
12 13 
KOH, 
EtOH + 
14 
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I2, 
KOAc 
14 
16 15 
AlBr3 
16 
Me2SO4 
K2CO3 
17 18 
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Results and discussion 
Our synthesis of chrysosplenol D (2) involved the synthesis of a chalcone 
intermediate from aldol condensation of ketone 12 with aldehyde 13 which would be 
subjected to oxidation to a flavone then to flavonol, methylation, and deprotection.  
 
 
 
     
 
                 
 
 
 
Ketone 12 was synthesized by O-acetylation of commercially available 3, 4, 5-
trimethoxyphenol (20), followed by boron trifluoride-catalyzed Fries rearrangement of 21 to 
afforded ketone 12 in high yield (96 %) (Scheme 5).
12
 Aldehyde 13 was obtained with good 
yield (67 %) by protecting commercially available 3, 4-dihydroxybenzaldehyde (22) with 
benzyl bromide (Scheme 6).
13
  
14 12 
+ 
13 
Chrysosplenol D (2) 19 16 
Scheme 4. Retrosynthesis of chrysosplenol D 
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An aldol condensation between ketone 12 and aldehyde 13 gave the chalcone 14 in 
84 % yield (Scheme 7).
14 
Ketone 12 and aldehyde 13 had similar Rf values. To avoid 
purification problems, excess ketone was used to complete the consumption of the aldehyde. 
 
 
  
 
 
In the Kraus and Roy synthesis of chrysosplenol D (2), they obtained a flavonol as the 
product in the AFO oxidation. They obtained dihydroflavonol 15 and then formed  
Benzyl bromide 
K2CO3, acetone 
13 22 
Scheme 5 
Scheme 6 
Scheme 7 
Ac2O 
AcONa 
BF3-Et2O 
12 20 21 
KOH 
EtOH 
14
5 
12 13 + 
 9 
flavonol 16 by iodine oxidation.
6
 However, the AFO reaction did not work well for the 
synthesis of o-methoxyflavones as shown in Scheme 8. This reaction gave mostly starting 
material.  
  
 
 
 
 Therefore, we tried different routes. Dimethyldioxirane (DMDO) (23) has proven to 
be a very useful epoxidising agent, forming epoxide in good yields. Burke and O’Sullivan  
showed the successful epoxidation of unsubstituted (E)-2’-hydroxychalcone (24) to (E)-2’-
hydroxychalcone epoxide (25) and also observed cyclisation of (E)-2’-hydroxychalcone (24) 
to trans-2,3-dihydroflavonol (26) as shown in Scheme 10.
15
 We have synthesized  
DMDO (23) using simplified procedure employed by Murray and Singh as shown in Scheme 
9.16 With our hydroxychalcone 14, we cyclized the chalcone using DMDO (23)
15
 and then 
formed flavonol 16 by iodine oxidation
6
 as shown in Scheme 11. However, the reaction gave 
low yield (< 5 %) due to low concentration of DMDO (23). This reaction gave mostly 
starting material. 
 
 
 
Scheme 8 
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H2O2 
NaOH 
MeOH 
X 14 
15 
Scheme 9. Synthesis of dimethyldioxirane (DMDO) (23) 
NaHCO3 
H2O 
+ 
Oxone 
(Potassium 
peroxymonosulfate) 
Acetone 
Dimethyldioxirane (23) 
 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 We tried oxidizing the chalcone 14 to flavone 19.
17
 The reaction with iodine gave a 
low yield (< 10 %) and intractable mixture of compounds. 
 
 
 
   
 
 
 
I2 
DMSO 
140 °C 
14 
19 
Scheme 12 
Scheme 10 
16 
Scheme 11 
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24
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24 
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 Mahal and coworkers oxidized dimethoxymonobenzyloxy chalcones by means of 
selenium dioxide oxidation in amyl alcohol (Scheme 13).
18
 Since we had a similar system, 
we tried an oxidation using selenium dioxide to yield flavone 19 in 75 % yield (Scheme 14). 
 
 
 
 
 
 
   
 
    
 With flavone 19 in hand, flavonol 16 was produced using DMDO (23) as shown in 
Scheme 15.
17
 However, the reaction went in low yield (17 % maximum) and also gave 
demethylated compound. Flavonol 16 and the demethylated compound had similar Rf values 
and created purification problems.  
  
  
  
 
Scheme 15 
1. DMDO (23), CH2Cl2 
2. p-TsOH, CHCl3 
19 
16 
Scheme 14 
14 
SeO2 
Amyl alcohol 
19 
Scheme 13 
SeO2 
Amyl alcohol 
27 28 
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  Adams and coworkers proposed an alternative oxidation procedure involving 
deprotonation, oxidation, and hydrolysis as shown in Scheme 16.
19
 The reaction proceeded 
via an anion at C-3 position from deprotonation of 19 with lithium diisopropylamide (LDA) 
which was trapped by trimethylborate. The resulting borate was oxidized using hydrogen 
peroxide to give flavonol 16 in 62 % yield.  
 
 
 
 
 
 
 
 
 
  
  
 Flavonol 16 was methylated to afford 3-methoxyflavone 17. Aluminum tribromide 
mediated selective demethylation
6
 of 17 and debenzylation
6
 of 18 using a catalytic amount of 
10 % Pd/C afforded chrysosplenol D (2) in 60 % yield. The overall yield from 12 is 15 %. 
Scheme 17 
Scheme 16 
16 
19 LDA, B(OMe)3 
Acetic acid, H2O2 
 
LDA, B(OMe)3 
Acetic acid, H2O2 
 
29 30 
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 To investigate the activities of the functional groups, two more derivatives of 
chrysosplenol D (2) were synthesized. Compounds 3’, 4’-dibenzyloxy-3-hydroxy-5, 6, 7-
trimethoxyflavone (16), and 3’, 4’-dibenzyloxy-3, 5, 6, 7-tetramethoxyflavone (17) were 
debenzylated to form analogs 31 and 32, respectively. 
 
 
 
   
  
 
 
Chrysosplenol D (2) 
H2 
Pd/C 
 
18 
Me2SO4 
K2CO3 
 
AlBr3 
 16 
18 17 
Scheme 18 
Scheme 19 
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31 16 
H2 
Pd/C 
 
17 32 
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 Chrysosplenol B (1) has a similar structure as chrysosplenol D (2) and was 
synthesized in similar manner. The synthesis started with an aldol condensation between 
ketone 12 and aldehyde 33 which formed chalcone 34, which was oxidized by selenium 
dioxide to form flavone 35. Then flavone 35 was further oxidized by LDA and H2O2 which 
was methylated to afford 3-methoxyflavone 37. Aluminum tribromide mediated selective 
demethylation of 37 and debenzylation of 38 using a catalytic amount of 10 % Pd/C afforded 
chrysosplenol B (1) in 67% yield. The overall yield from 12 is 16 %. 
 
 
  
 
    
 
 
  
 
       
  
LDA, B(OMe)3 
Acetic acid, 
H2O2 
 
SeO2 
Amyl alcohol 
36 
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35 
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36 
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Pd/C 
 
38 
33 
KOH, 
EtOH 
12 
+ 
34 
Scheme 20.  Synthesis of chrysosplenol B (1) 
 15 
 Similar to chrysosplenol D (2), two more derivatives of chrysosplenol B (1) were 
synthesized. Both 4’-benzyloxy-3-hydroxy-5, 3’, 6, 7-tetramethoxyflavone (36) and 4’-
benzyloxy-3, 5, 3’, 6, 7-pentaoxyflavone (37) were debenzylated to form 39 and 40, 
respectively.   
 
  
 
  
 
 
 
 
In conclusion, we have synthesized chrysosplenol B (1), chrysosplenol D (2) and their 
analogs. Both chrysosplenol B (1) and chrysosplenol D (2) have the flavone skeleton with 3-
methoxyl and 5-hydroxyl groups which have ability to potentiate the anti-malarial activity of 
artemisinin and the activity of norfloxacin. The synthesis started from 1-(6-hydroxy-2, 3, 4-
trimethoxyphenyl)ethanone (12) for both natural products. Chrysosplenol B (1) was 
synthesized in six steps with 16 % overall yield. Chrysosplenol D (2) was also synthesized in 
six steps with 15 % overall yield. Our synthesis has led to an alternative method of forming 
flavones from chalcones using selenium dioxide.  
Scheme 21 
36 39 
H2 
Pd/C 
 
40 
H2 
Pd/C 
 
37 
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Experimental section 
General.  
 All 
1
H NMR spectra were recorded at 300 MHz or 400 MHz unless otherwise noted. 
Unless otherwise noted, reactions were carried out under an argon atmosphere. Thin-layer 
chromatography was performed using commercially prepared 60-mesh silica gel plates 
(Whatman K6F), and visualization was effected using short wavelength UV light (254 nm). 
All reagents were used directly as obtained commercially unless otherwise noted. 
 
3, 4, 5-Trimethoxyphenyl acetate (21).  
 To a stirred solution of 3, 4, 5-trimethoxyphenol (20) (5.0 g, 27 mmol) in acetic 
anhydride (25 mL, 0.27 mol) at room temperature was added sodium acetate (5.0 g, 61 
mmol). The mixture was heated for 2 hours at 110 °C. The mixture was concentrated under 
vacuum, diluted with water, and extracted with dichloromethane (3 x 25 mL), and dried over 
anhydrous MgSO4. The solvent was evaporated to yield 3, 4, 5-trimethoxyphenyl acetate 21 
(5.92 g, 96 % yield) as a light brown oil.
12
 
 
1-(6-Hydroxy-2, 3, 4-trimethoxyphenyl)ethanone (12). 
  To a stirred solution of acetate 21 (3.0 g, 13 mmol) in glacial acetic acid (3 mL) at 
room temperature was added dropwise boron trifluoride-diethyl ether (6.0 mL, 47 mmol). 
The mixture was heated for 2 hours at 70 °C. It was cooled and then poured into 10 % 
aqueous NaOH (125 mL). The mixture was washed with ether, the aqueous layer was cooled, 
acidified with concentrated HCl, then extracted with dichloromethane. The combined organic 
 17 
layers were dried over anhydrous MgSO4. The solvent was evaporated, and the crude residue 
was purified by silica gel column chromatography (hexanes/EtOAc, 3:1) to yield compound 
12 (2.56 g, 85 % yield) as a brown oil: 
1
H NMR (400 MHz, CDCl3) δ 6.23 (s, 1H), 3.98 (s, 
3H), 3.88 (s, 3H), 3.77 (s, 3H), 2.65 (s, 3 H).
12
 
 
3, 4-Dibenzyloxybenzaldehyde (13).  
  To a stirred solution of 3, 4-dihydroxybenzaldehyde (22) (2.0 g, 14.5 mmol) in 
acetone (40 mL) at room temperature was added benzyl bromide (5.2 mL, 44 mmol), and 
potassium carbonate (9.0 g, 66 mmol). The mixture was heated to reflux for 4 hours. After 
completion of the reaction, the solid material was filtered off, and the solvent was evaporated. 
The residue was purified by silica gel column chromatography (hexanes/EtOAc, 95:5) to 
yield compound 13 (3.07 g, 67 % yield) as white solid: mp 84-87 °C: 
1
H NMR (400 MHz, 
CDCl3) δ 9.81 (s, 1H), 7.38-7.32 (m, 12H), 7.02 (d, 1H), 5.27 (s, 2H), 5.22 (s, 2H).
13
 
 
3’, 4’Dibenzyloxy-6-hydroxy-2, 3, 4-trimethoxychalcone (14).  
  To a stirred solution of ketone 12 (1.3 g, 5.7 mmol) and aldehyde 13 (1.5 g, 4.7 mmol) 
in EtOH (50 mL) at 0 °C was added freshly powdered KOH (89.2%, 1.5 g, 24 mmol). The 
mixture was boiled for 24 hours. The solvent was evaporated to approximately one-fifth the 
original volume. Ice-cold H2O (~ 3mL) was added, and the mixture was neutralized with 2 N 
HCl. The mixture was extracted with ethyl acetate (3 x 50 mL) and dried over anhydrous 
MgSO4. The solvent was evaporated, and the crude residue was purified by silica gel column 
chromatography (hexanes/EtOAc, 3:1) to yield compound 14 (2.08 g, 84 % yield) as a 
 18 
yellow oil:  
1
H NMR (400 MHz, CDCl3) δ 7.74 (s, 2H), 7.49-7.25 (m, 11H), 7.21 (s, 1H), 
6.94 (d, 1H, J = 8.4 Hz), 6.29 (s, 1H), 5.23 (s, 4H), 3.90 (s. 3H), 3.84 (s, 6H).
6
 
 
3’, 4’-Dibenzyloxy-5, 6, 7-methoxyflavone (19).  
  To a stirred solution of chalcone 14 (1.0 g, 1.9 mmol) in amyl alcohol (25 mL) at 
room temperature was added selenium dioxide (0.74 g, 6.6 mmol). The mixture was heated at 
136 °C for 12 hours. After completion of the reaction, the selenium was filtered and washed 
with ether. The combined solutions were extracted with 20 % aqueous NaOH and dried over 
anhydrous MgSO4. The solvent was evaporated, and the crude residue was purified by silica 
gel column chromatography (hexanes/EtOAc, 1:1) to yield compound 19 (0.75 g, 75 % yield) 
as a yellow oil: 
1
H NMR (400 MHz, CDCl3) δ 7.49-7.35 (m, 12H), 7.00 (d, 1H), 6.74 (s, 1H), 
6.52 (s, 1H), 5.25 (s, 4H), 3.98 (s, 6H), 3.92 (s, 3H).
21
 
 
3’, 4’-Dibenzyloxy-3-hydroxy-5, 6, 7-trimethoxyflavone (16).  
 Using dimethyldioxirane: 
 To a stirred solution of chalcone 19 (0.1 g, 0.19 mmol) in dichloromethane (4 mL) at 
0 °C was added dimethyldioxirane (8 mL). The mixture was stirred at 4 °C under Argon gas 
overnight. The solvent was evaporated and the residue was dissolved in chloroform (5 mL) 
and then catalytic amount of p-toluenesulfonic acid was added. The mixture was stirred at 
0 °C for 30 minutes. The solvent was evaporated, and the crude residue was purified by silica 
gel column chromatography (hexanes/EtOAc, 5:2) to yield compound 16 (18 mg, 17 % yield) 
 19 
as a yellow oil: 
1
H NMR (400 MHz, CDCl3) δ 7.52-7.29 (m, 12H), 7.02 (d, 1H), 6.71 (s, 1H), 
6.49 (s, 1H), 5.22 (s, 4H), 3.97 (s, 6H), 3.92 (s, 3H).
6
 
 
Using lithium diisopropylamide: 
 To a stirred solution of diisopropylamine (0.06 mL, 0.46 mmol) in THF (2 mL) at  
-78 °C was added butylithium. The mixture was stirred for 30 minutes at -78 °C. A solution 
of flavone 19 (0.20 g, 0.38 mmol) in THF (5 mL) was added dropwise at -78 °C.  After 5 
minutes, a solution of freshly distilled trimethyl borate in THF (1 mL) was added and the 
mixture was stirred for 40 minutes at -78 °C. Glacial acetic acid (30 μL, 0.06 mmol) was 
added followed by 30 % hydrogen peroxide (45 μL). The reaction was allowed to warm to 
room temperature for 1 hour and quenched with saturated NaHCO3. The mixture was 
extracted with EtOAc and dried over anhydrous MgSO4. The solvent was evaporated, and the 
crude residue was purified by silica gel column chromatography (hexanes/EtOAc, 1:1) to 
yield compound 16 (0.13 g, 62 % yield) as a yellow oil: 
1
H NMR (400 MHz, CDCl3) δ 7.90 
(s, 1H), 7.89 (d, 1H), 7.80-7.27(m, 10H), 7.04 (d, 1H), 6.73 (s, 1H), 5.28 (s, 4H), 4.03 (s, 3H), 
4.00 (s, 3H), 3.93 (s, 3H).
6
 
 
3’, 4’- Dibenzyloxy-3, 5, 6, 7-tetramethoxyflavone (17).  
  To a stirred solution of flavonol 16 (100 mg, 0.19 mmol) and anhydrous K2CO3 (230 
mg, 1.66 mmol) in dry acetone (5 mL) at room temperature, Me2SO4 (210 mg, 1.66 mmol) 
was added dropwise. The mixture was heated for 9 hours. The solvent was removed, and the 
crude residue was purified by silica gel column chromatography (hexanes/EtOAc, 1:1) to 
 20 
yield compound 17 (84 mg, 82 % yield) as a yellow oil: 
1
H NMR (400 MHz, CDCl3) δ 7.77 
(s, 1H), 7.65, (d, 1H), 7.50-7.32 (m, 10H), 7.01 (s, 1H), 6.67 (s, 1H), 5.27 (s, 4H), 4.00 (s, 
3H), 3.96 (s, 3H), 3.91 (s, 3H), 3.72 (s, 3H).
6
 
 
3’, 4’-Dibenzyloxy-5-hydroxy-3, 6, 7-trimethoxyflavone (18).  
  To a stirred solution of 3-methoxyflavone 17 (70 mg, 0.13 mmol) in MeCN (1 mL) at 
0 °C, was added dropwise a solution of AlBr3 (236 mg, 0.88 mmol) in MeCN (3.5 mL). The 
mixture was stirred at 0 °C, for 20 minutes, and then 2 % aqueous HCl solution (7.5 mL) was 
added. The solution was heated at 75 °C for 25 minutes and then cooled to room temperature. 
The solvent was evaporated, extracted with CH2Cl2 (2x25 mL), and dried over Na2SO4. The 
solvent was evaporated and the crude residue was purified by silica gel column 
chromatography (hexanes/EtOAc, 3:2) to yield compound 18 (53 mg, 78 % yield) as a 
yellow oil : 
1
H NMR (300 MHz, CDCl3) δ 7.76 (s, 1H), 7.65, (s, 1H), 7.48-7.33 (m, 10H), 
7.05 (d, 1H, J = 9.0 Hz), 6.44 (s, 1H), 5.27 (s, 4H), 4.15 (s, 3H), 3.95 (s, 3H), 3.71 (s, 3H).
6
 
 
Chrysosplenol D (2).  
  A mixture of 3-methoxyflavone 18 (40 mg, 0.074 mmol) and a catalytic amount of 
10 % Pd/C in MeOH/EtOAc (20 mL, 1:1) was stirred in H2 atmosphere at room temperature 
for 1 hour. The mixture was purified by silica gel column chromatography (hexanes/EtOAc, 
1:1) to yield the natural product 2 (16 mg, 60 % yield) as a yellow oil: 
1
H NMR (400 MHz, 
CDCl3) δ 7.86 (d, 1H), 7.56 (d, 1H), 7.16 (s, 1H), 6.42 (s, 1H), 4.09 (s, 3H), 3.93 (s, 3H), 
3.75 (s, 3H).
6
  
 21 
3, 3’, 4’-Trihydroxy-5, 6, 7-trimethoxyflavone (31).  
  A mixture of flavonol 16 (30 mg, 0.055 mmol) and a catalytic amount of 10 % Pd/C 
in MeOH/EtOAc (15 mL, 1:1) was stirred in H2 atmosphere at room temperature for 1 hour. 
The mixture was purified by silica gel column chromatography (hexanes/EtOAc, 1:1) to 
yield compound 31 (13 mg, 65 % yield) as a yellow oil: 
1
H NMR (300 MHz, CDCl3) δ 7.74 
(s, 1H), 7.62 (d, 1H), 7.46 (d, 1H), 6.70 (s, 1H), 3.96 (s, 3H), 3.90 (s, 3H), 3.85 (s, 3H). 
 
3’, 4’-Dihydroxy-3, 5, 6, 7-tetramethoxyflavone (32).  
  A mixture of 3-methoxyflavone 17 (60 mg, 0.108 mmol) and a catalytic amount of 
10 % Pd/C in MeOH/EtOAc (30 mL, 1:1) was stirred in H2 atmosphere at room temperature 
for 1 hour. The mixture was purified by silica gel column chromatography (hexanes/EtOAc, 
1:1) to yield compound 32 (28mg , 69 % yield) as a yellow oil: 
1
H NMR (400 MHz, CDCl3) 
δ 7.78 (s, 1H), 7.66, (d, 1H), 7.00 (s, 1H), 6.64 (s, 1H), 3.98 (s, 3H), 3.95 (s, 3H), 3.89 (s, 
3H), 3.75 (s, 3H).
22
 
 
4-Benzyloxy-3-methoxybenzaldehyde (33).  
  To a stirred solution of 4-hydroxy-3-methoxybenzaldehyde (12) (2.0 g, 13mmol) in 
acetone (40 mL) at room temperature was added benzyl bromide (2.3 mL, 20 mmol), and 
potassium carbonate (4.5 g, 33 mmol). The mixture was boiled for 4 hours. After completion 
of the reaction, the solid material was filtered off, and the solvent was evaporated. The 
residue was purified by silica gel column chromatography (hexanes/EtOAc, 95:5) to yield 
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compound 33 (2.7 g, 84 % yield) as white solid: mp 87-90 °C: 
1
H NMR (400 MHz, CDCl3)  
δ 9.81 (s, 1H), 7.44-7.31 (m, 7H), 6.98 (d, 1H), 5.21 (s, 2H), 3.91 (s, 3H).20 
 
 4’-Benzyloxy-6-hydroxy-2, 3, 4, 3’-tetramethoxychalcone (34).  
  To a stirred solution of ketone 12 (1.1 g, 5.0 mmol) and aldehyde 33 (1.0 g, 4.1 mmol) 
in EtOH (40 mL) at 0 °C was added freshly powdered KOH (89.2%, 1.3 g, 21 mmol). The 
mixture was boiled for 24 hours. The solvent was evaporated to approximately one-fifth the 
original volume. Ice-cold H2O (~ 3mL) was added, and the mixture was neutralized with 2 N 
HCl. The mixture was extracted with ethyl acetate (3 x 50 mL) and dried over anhydrous 
MgSO4. The solvent was evaporated, and the crude residue was purified by silica gel column 
chromatography (hexanes/EtOAc, 3:1) to yield compound 34 (1.4 g, 75 % yield) as a yellow 
oil: 
1
H NMR (400 MHz, CDCl3) δ 7.71 (s, 1H), 7.46-7.28 (m, 7H), 7.22 (s, 1H), 6.94 (d, 1H), 
6.27 (s, 1H), 5.20 (s, 2H), 3.97 (s, 6H), 3.96 (s, 3H), 3.91 (s, 3H).
14
 
 
4’-Benzyloxy-5, 6, 7, 3’-tetramethoxyflavone (35).  
  To a stirred solution of chalcone 34 (1.0 g, 2.2 mmol) in amyl alcohol (25 mL) at 
room temperature was added selenium dioxide (0.86 g, 7.8 mmol). The mixture was boiled at 
136 °C for 12 hours. After completion of the reaction, the selenium was filtered off and 
washed with ether. The combined solutions were extracted with 20 % aqueous NaOH and 
dried over anhydrous MgSO4. The solvent was evaporated, and the cr,ude residue was 
purified by silica gel column chromatography (hexanes/EtOAc, 1:1) to yield compound 35 
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(0.76 g, 76 % yield) as a yellow oil: 
1
H NMR (400 MHz, CDCl3) δ 7.43-7.29 (m, 7H), 6.95 
(d, 1H), 6.75 (s, 1H), 6.54 (s, 1H), 5.19 (s, 2H), 3.96 (s, 6H), 3.94 (s, 3H), 3.89 (s, 3H).
21
 
 
4’-Benzyloxy-3-hydroxy-5, 6, 7, 3’-tetramethoxyflavone (36).  
  To a stirred solution of diisopropylamine (0.12 mL, 1.6 mmol) in THF (1 mL) at  
-78 °C was added butylithium. The mixture was stirred for 30 minutes at -78 °C. A solution 
of flavone 33 (600 mg, 1.3 mmol) in THF (10 mL) was added dropwise at -78 °C.  After 5 
minutes, a solution of freshly distilled trimethyl borate in THF (2 mL) was added and the 
mixture was stirred for 40 minutes at -78 °C. Glacial acetic acid (60 μL, 0.12 mmol) was 
added followed by 30 % hydrogen peroxide (90 μL). The reaction was allowed to warm to 
room temperature for 1 hour and quenched with saturated NaHCO3. The mixture was 
extracted with EtOAc and dried over anhydrous MgSO4. The solvent was evaporated, and the 
crude residue was purified by silica gel column chromatography (hexanes/EtOAc, 1:1) to 
yield compound 36 (0.38 g, 61 % yield) as a yellow oil: 
1
H NMR (400 MHz, CDCl3) δ 7.87 
(s, 1H), 7.86 (d, 1H), 7.79-7.28 (m, 5H), 7.02 (d, 1H), 6.72 (s, 1H), 5.24 (s, 2H), 3.98 (s, 6 H), 
3.96 (s, 3H), 3.90 (s, 3H).
8
 
 
4’-Benzyloxy-3, 5, 6, 7, 3’-pentamethoxyflavone (37).  
  To a stirred solution of flavonol 36 (200 mg, 0.43 mmol) and anhydrous K2CO3 (534 
mg, 3.9 mmol) in dry acetone (10 mL) at room temperature, Me2SO4 (488 mg, 3.87 mmol) 
was added dropwise. The mixture was boiled for 9 hours. The solvent was removed, and the 
crude residue was purified by silica gel column chromatography (hexanes/EtOAc, 1:1) to 
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yield compound 37 (174 mg, 84 % yield) as a yellow oil: 
1
H NMR (400 MHz, CDCl3) δ 7.74 
(s, 1H), 7.61 (d, 1H), 7.54-7.28 (m, 5H), 6.98 (s, 1H), 6.63 (s, 1H), 5.22 (s, 2H), 3.99 (s, 6H), 
3.97 (s, 3H), 3.89 (s, 3H), 3.74 (s, 3H).
22
 
 
4’-Benzyloxy-5-hydroxy-3, 6, 7, 3’-tetramethoxyflavone (38).  
 To a stirred solution of 3-methoxyflavone 37 (100 mg, 0.21 mmol) in MeCN (2 mL) 
at 0 °C, was added dropwise a solution of AlBr3 (390 mg, 1.46 mmol) in MeCN (5 mL). The 
mixture was stirred at 0 °C, for 20 minutes, and then 2 % aqueous HCl solution (10 mL) was 
added. The solution was boiled at 75 °C for 25 minutes and then cooled to room temperature. 
The solvent was evaporated, extracted with CH2Cl2 (2x25 mL), and dried over Na2SO4. The 
solvent was evaporated and the crude residue was purified by silica gel column 
chromatography (hexanes/EtOAc, 3:2) to yield compound 38 (79 mg, 81 % yield) as a 
yellow oil: 
1
H NMR (400 MHz, CDCl3) δ 7.72 (s, 1H), 7.59, (s, 1H), 7.56-7.29 (m, 5H), 7.01 
(d, 1H), 6.41 (s, 1H), 5.24 (s, 2H), 3.97 (s, 6H), 3.89 (s, 3H), 3.71 (s, 3H).
22
 
 
Chrysosplenol B (1).  
  A mixture of 3-methoxyflavone 38 (60 mg, 0.13 mmol) and a catalytic amount of 10% 
Pd/C in MeOH/EtOAc (25 mL, 1:1) was stirred in H2 atmosphere at room temperature for 1 
hour. The mixture was purified by silica gel column chromatography (hexanes/EtOAc, 1:1) 
to yield the natural product 1 (32 mg, 67 % yield) as a yellow oil: 
1
H NMR (400 MHz, 
CDCl3) δ 7.79 (s, 1H), 7.63 (d, 1H), 7.19 (s, 1H), 6.57 (s, 1H), 4.00 (s, 6H), 3.92 (s, 3H), 3.72 
(s, 3H).
10
 
 25 
3, 4’-Dihydroxy-5, 6, 7, 3’-tetramethoxyflavone (39).  
  A mixture of flavonol 36 (40 mg, 0.086 mmol) and a catalytic amount of 10 % Pd/C 
in MeOH/EtOAc (20 mL, 1:1) was stirred in H2 atmosphere at room temperature for 1 hour. 
The mixture was purified by silica gel column chromatography (hexanes/EtOAc, 1:1) to 
yield compound 39 (19 mg, 59 % yield) as a yellow oil: 
1
H NMR (400 MHz, CDCl3) δ 7.77 
(s, 1H), 7.67 (d, 1H), 7.43 (d, 1H), 6.68 (s, 1H), 3.98 (s, 6H), 3.91 (s, 3H), 3.87 (s, 3H).
8
 
 
4’-Hydroxy-3, 5, 6, 7, 3’-pentamethoxyflavone (40).  
  A mixture of 3-methoxyflavone 37 (40 mg, 0.084 mmol) and a catalytic amount of 
10 % Pd/C in MeOH/EtOAc (40 mL, 1:1) was stirred in H2 atmosphere at room temperature 
for 1 hour. The mixture was purified by silica gel column chromatography (hexanes/EtOAc, 
1:1) to yield compound 40 (20 mg, 63 % yield) as a yellow oil: 
1
H NMR (400 MHz, CDCl3) 
δ 7.78 (s, 1H), 7.67 (d, 1H), 7.13 (d, 1H), 6.68 (s, 1H), 3.98 (s, 6H), 3.91 (s, 3H), 3.87 (s, 3H), 
3.71 (s, 3H).
7
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CHAPTER 2 
Synthesis of 3-(carboxymethylthio)-picolinic acid and its analog 
 
Introduction 
 Phosphenolpyruvate carboxykinase (PEPCK) is an enzyme used in the natural 
process of gluconeogenesis.
1
 It converts oxaloacetate (OAA) to phosphoenolpyruvate (PEP), 
using GTP or ITP as the phosphoryl donor. In vertebrates, PEPCK occurs as two distinct 
isozymes, cytosolic and mitochondrial, which are products of different genes.
2-5
 Most 
reactions of gluconeogenesis can use the glycolysis enzymes in the opposite direction; 
however, the pyruvate kinase enzyme is irreversible. Therefore, the enzymes pyruvate 
carboxylase and phosphoenolpyruvate carboxykinase are used to provide an alternate path 
for effectively reversing its actions.  
  Transcription of the PEPCK gene is stimulated by glucagon, glucocorticoids, retinoic 
acid, and adenosine 3’, 5’-monophosphate (cAMP), while it is inhibited by insulin. Insulin 
inhibits the transcription of many of the stimulatory elements and, therefore, considered 
dominant of these factors. PEPCK activity is also inhibited by hydrazine sulfate, and the 
inhibition decreases the rate of gluconeogenesis. Also, the use of siRNA to inhibit PEPCK in 
a diabetic mouse model shows elimination of the hyperglycemia upon PEPCK inhibition. 
Therefore, it would be advantageous to find novel inhibitors of PEPCK and/or an inhibitor 
scaffold for preparing analogs and derivatives for novel inhibitors of PEPCK.
1,2
 
  In efforts to characterize the active sites of the isozymes of PEPCK, studies have been 
performed using analogs of PEP or OAA, either as reversible inhibitors or as alternative 
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substrates. Derivatives of PEP with alkyl or halo substitutions have been used to demonstrate 
the stereospecificity of the reaction catalyzed by mitochondrial PEPCK (mPEPCK) from 
avian liver.
6-9
 Studies have shown that α-hydroxyl and α-sulfhydryl carboxylic acids are poor 
substrates for that enzyme’s phosphoryl transfer reaction.1, 2, 6  
 The molecular structure configuration for interacting with a binding site of PEPCK 
was investigated to find novel inhibitors of PEPCK. The PEPCK inhibitors are characterized 
by having a size capable of fitting into and interaction with the PEPCK binding site and at 
least one of the following: (a) a first terminal substituent have co-planar atoms acting as 
metal ligands to the active site metal ion PEPCK; (b) at least one of an atom or substituent at 
positions 2 or 3 from the first terminal substituent includes a neutral carbon center or include 
an oxygen, sulfur, selenium, or other atom with similar physiochemical properties; (c) at least 
one of an atom or substituent at positions 2 or 3 from the first terminal substituent is devoid 
of an electropositive atom or substituent; or (d) a second terminal substituent opposite of the 
first terminal substituent, having an atom that is a hydrogen bonding acceptor and/or is 
negatively charged.
1
  
   Holyoak and others also concluded the ability of substrate analogs to inhibit PEPCK 
depended upon their overall size and the orientation, electronic properties and charge of their 
functional groups. His study systematically evaluated substrate analogs of PEP and OAA as 
reversible inhibitors of PEPCK when tested against PEP. With the exception of three 
compounds, all were bifunctional, being predominantly bicarboxylic acids, biphosphonic 
acids, or bisulfonic acids. Some of the bifunctional compounds were also phosphoryl or 
sulfonyl monocarboxylic acids. The structure-function analysis illustrated the mechanism of 
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molecular recognition used by PEPCK, which could be exploited to develop novel and 
selective inhibitors of the enzyme.
 1, 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Knowing some characteristics of the inhibitors, development of novel inhibitors of 
the enzyme has been studied. One of the most important criteria in choosing compounds for 
the inhibitors was that they possess functional groups similar to those of the substrates. 
Therefore, we focused on synthesizing compounds which were bicarboxylate and 
bicarboxylate with sulfonyl group, 3-(carboxymethylthio)-picolinic acid (1) and its analog,  
3-(Carboxymethylsulfonyl)-
picolinic acid (2) 
3-(Carboxymethylthio)-
picolinic acid (1) 
Figure 1. Four different picolinic acid compounds 
3-(Carboxymethylamino)-
picolinic acid (4) 
3-(Carboxymethoxy)-
picolinic acid (3) 
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3-(carboxymethylsulfonyl)-picolinic acid (2) as shown in Figure 1. In the past,  
3-(carboxymethoxy)-2-picolinic acid (3) and 3-(carboxymethylamino)-picolinic acid (4) 
were known and studied.
10- 12
 However, 3-(carboxymethylthio)-picolinic acid (1) is not a 
very well known compound. Only one synthesis of 3-(carboxymethylthio)-picolinic acid (1) 
has been reported in 1926 by Plazek and Sucharda.
12
 The synthesis of 3-
(carboxymethylthio)-picolinic acid (1) was carried by the same route. The analog of 3-
(carboxymethylthio)-picolinic acid (1), 3-(carboxymethylsulfonyl)-picolinic acid (2) was 
synthesized by oxidation with dimethyldioxirane (DMDO).
15
 
 
Results and discussion 
 When the synthesis of 3-(carboxymethylthio)-picolinic acid (1) was started, there was 
only one direct synthesis reported for this compound. Our synthesis of  
3-(carboxymethylthio)-picolinic acid (1) was started by reproducing method employed by 
Plazek and Sucharda as shown in Scheme 1.
12
 The reaction started with commercially 
available β-aminopicolinic acid. At first trial, reaction gave very low yield (< 5%) after silica 
gel column chromatography with intractable mixture of compounds that was not investigated 
any further. 
 
 
 
HCl 
NaNO2 
 
+ 
5 6 1 
Scheme 1 
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With low yield, we searched for different route. Calandra and coworkers developed a 
route toward internally disulfide protected β-mercaptoalcohol 8 as shown in Scheme 2.13 
 
 
 
 
With similar connectivity, we incorporated this route to our synthesis toward  
3-(carboxymethylthio)-picolinic acid. Our synthesis began using commercially available  
3-mercaptopicolinic acid as shown in Scheme 3. However this reaction only gave starting 
material. Therefore, we tried heating the reaction; however, again it only returned starting 
material. Then, we tried using a different solvent. Instead of tetrahydrofuran (THF), we used 
dimethylformamide (DMF) for the solvent. With DMF, we got some starting material and 
intractable mixture of compounds, but no desired product. 
 
 
 
 
 
 
9 11 
Scheme 2 
Scheme 3 
+ Br2CH2CO2H 
NaH, THF 
0 °C to rt 
 
X 
NaH, THF 
Δ 
 
X 
NaH, DMF 
0 °C to rt 
 
X 
10 
Br2CH2CO2H 
NaH, THF 
0 °C to rt 
 
7 8 
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 While searching for another route, we found a paper which also followed the method 
by Plazek and Sucharda and was able to obtain 3-(carboxymethylthio)-picolinic acid.
14
 With 
this proof, we have reproduced the method by Plazek and Sucharda again. This trial, again, 
gave very low yield (< 5%) after silica gel column chromatography with intractable mixture 
of compounds. However, we were able to increase yield by recrystallization. Somehow 
1
H 
NMR spectra of crude product showed more pure product than recrystallized product. 
Therefore this compound was sent to Dr. Holyoak without purification to test for its activity. 
 Since we had some experience with dimethyldioxirane (DMDO), we have used 
DMDO to oxidize 3-(carboxymethylthio)-picolinic acid (1) to synthesize  
3-(carboxymethylsulfonyl)-picolinic acid (2). We have had problems with the concentration 
of DMDO, therefore we used excess DMDO to react with 3-(carboxymethylthio)-picolinic 
acid (1) as shown in Scheme 4
15
. This reaction was carried smoothly with yield of 32 %.
 
 
 
 
 
  
 In conclusion, we have successfully synthesized 3-(carboxymethylthio)-picolinic acid 
(1) and 3-(carboxymethylsulfonyl)-picolinic acid (2). Both of these compounds are 
bicarboxylates, 3-(carboxymethylsulfonyl)-picolinic acid (2) with sulfonyl group which 
Scheme 4 
xs. DMDO 
MeOH 
0 °C  rt 
 1 2 
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meets criteria in choosing compounds that they possess functional groups similar to those of 
the substrates, OAA and PEP.  These compounds can help researchers to study the 
mechanisms of molecular recognition of phosphoenolpyruvate and oxaloacetate by cytosolic 
phosphoenolpyruvate carboxykinase. 
 
Experimental section 
General.  
 All 
1
H NMR spectra were recorded at 300 MHz or 400 MHz unless otherwise noted. 
Unless otherwise noted, reactions were carried out under an argon atmosphere. Thin-layer 
chromatography was performed using commercially prepared 60-mesh silica gel plates 
(Whatman K6F), and visualization was effected using short wavelength UV light (254 nm). 
All reagents were used directly as obtained commercially unless otherwise noted. 
 
3-(Carboxymethylthio)-picolinic acid (1).  
  To hot concentrated hydrochloric acid (2.2 mL), β-aminopicolinic acid (5) (1.5 g, 
10.6 mmol) was dissolved and then quickly cooled. Separated crystals were added in 
concentrated sodium nitrite solution (0.8 g). Clear, brownish liquid is poured into 0 °C of 
thioglycolic acid (6) (1.0 g, 10.9 mmol) in water (~2 mL). After 2 hours of stirring 1.5 mL of 
concentrated hydrochloric acid is added. The reaction was let stand overnight to obtain 
compound 1 (384 mg, 17 % yield) as a white solid: 
1
H NMR (300 MHz, CDCl3) δ 8.44 (d, 
1H), 8.22 (d, 1H), 7.73 (m, 1H), 3.90 (s, 2H); LRMS (EI): m/z 215 (M+2), 78, 45 (100%) 
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3-(Carboxymethylsulfonyl)-picolinic acid (2).  
  To a solution of 3-(carboxymethylthio)-picolinic acid (1) (100 mg, 0.469 mmol) in 
methanol (5 mL) was added dropwise DMDO in acetone at 0 °C. The solution was stirred to 
room temperature for 2 hours. After evaporation of the solvent, the residue was dried under 
vacuum to yield compound 2 (37 mg, 32 % yield) as a clear oil: 
1
H NMR (300 MHz, CDCl3) 
δ 8.63 (d, 1H), 8.53 (d, 1H), 8.15 (m, 1H), 4.32 (s, 2H). 
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GENERAL CONCLUSION 
 In the first chapter, we investigated the synthesis of chrysosplenol B, chrysosplenol D, 
and their analogs. We have modified the Kraus and Roy synthesis of chrysosplenol D. From 
Kraus and Roy synthesis, we were unable to obtain flavonols using Algar-Flynn-Olyamada 
reaction. However, this research has led to an alternative method of forming flavonols from 
chalcones. We have oxidized chalcones to flavones using selenium dioxide and further 
oxidized flavones to flavonols using lithium diisopropylamide, trimethylborate and hydrogen 
peroxide. With our modified method, we were able to synthesized chrysosplenol D in six 
steps from 1-(6-hydroxy-2, 3, 4-trimethoxyphenyl)ethanone in 15 %  yield. Chrysosplenol B 
was also synthesized in six steps from 1-(6-hydroxy-2, 3, 4-trimethoxyphenyl)ethanone in 
16 % yield. Both chrysosplenol B and chrysosplenol D have the flavone skeleton with 3-
methoxyl and 5-hydroxyl groups, which have ability to potentiate the potent anti-malarial 
activity of artemisinin and have ability to potentiate the activity of norfloxacin. 
 In the second chapter, we have synthesized 3-(carboxymethylthio)-picolinic acid and 
its analog, 3-(carboxymethylsulfonyl)-picolinic acid. Both of these compounds are 
bicarboxylates, 3-(carboxymethylsulfonyl)-picolinic acid with sulfonyl group which meets 
criteria in choosing compounds that they possess functional groups similar to those of the 
substrates, oxaloacetate, and phosphoenolpyruvate. These compounds can help researchers to 
study the mechanisms of molecular recognition of phosphoenolpyruvate and oxaloacetate by 
cytosolic phosphoenolpyruvate carboxykinase. 
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